Duragesic® (Fentanyl Transdermal System) Functionality Trial in Chronic Low Back Pain

PHASE4CompletedINTERVENTIONAL
Enrollment

358

Participants

Timeline

Start Date

June 30, 2002

Study Completion Date

January 31, 2004

Conditions
Low Back Pain
Interventions
DRUG

fentanyl

All Listed Sponsors
lead

PriCara, Unit of Ortho-McNeil, Inc.

INDUSTRY

NCT00237341 - Duragesic® (Fentanyl Transdermal System) Functionality Trial in Chronic Low Back Pain | Biotech Hunter | Biotech Hunter